This site is intended for health professionals only

Published on 19 September 2014

Share this story:
Twitter
LinkedIn

MSD presents first phase 3 data for Omarigliptin



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn